AAPL vs. LLY: Apple vs. Eli Lilly Stock Comparison
This page compares Apple (AAPL) with Eli Lilly (LLY) using performance and risk, profitability, financial strength, growth, dividends, and valuation metrics.
Performance
Cumulative Growth
Trailing Returns
Performance at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| 1-Year Return | 46.73% | 40.51% |
Risk
Drawdown
Risk at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| 1-Year Volatility | 22.69% | 38.09% |
| Beta | 1.10 | 0.51 |
| 3-Month Avg. Volume | 46.45M | 3.19M |
Company Profile
Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Eli Lilly (LLY) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AAPL | LLY |
|---|---|---|
| Name | Apple Inc. | Eli Lilly and Company |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 4,275.93 billion USD | 1,010.34 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 12, 1980 | June 1, 1972 |
| Security Type | Common Stock | Common Stock |
Valuation
Price-to-Earnings Ratio (TTM)
Both Apple (AAPL) at 35.20 and Eli Lilly (LLY) at 40.32 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AAPL
Technology Hardware & Equipment industry group
35.20
- Max
- 171.43
- Q3
- 83.19
- Median
- 39.13
- AAPL
- 35.20
- Q1
- 23.68
- Min
- 9.35
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
40.32
- Max
- 77.14
- Q3
- 43.78
- LLY
- 40.32
- Median
- 24.68
- Q1
- 15.27
- Min
- 1.70
Price-to-Sales Ratio (TTM)
Eli Lilly (LLY) at 13.98 is priced about in line with its industry on P/S ratio, while Apple (AAPL) at 9.47 sits in the pricier quartile — AAPL costs more per dollar of sales.
AAPL
Technology Hardware & Equipment industry group
9.47
- Max
- 19.39
- AAPL
- 9.47
- Q3
- 9.05
- Median
- 4.10
- Q1
- 1.42
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
13.98
- Max
- 55.38
- Q3
- 24.42
- LLY
- 13.98
- Median
- 6.98
- Q1
- 3.30
- Min
- 0.01
Price-to-Book Ratio (MRQ)
Measured against book value, both Apple (AAPL) at 40.10 and Eli Lilly (LLY) at 32.45 look expensive — each P/B ratio sits above its industry’s benchmark range.
AAPL
Technology Hardware & Equipment industry group
40.10
- AAPL
- 40.10
- Max
- 17.76
- Q3
- 9.32
- Median
- 4.56
- Q1
- 2.09
- Min
- -3.27
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
32.45
- LLY
- 32.45
- Max
- 13.23
- Q3
- 6.38
- Median
- 3.46
- Q1
- 1.64
- Min
- -5.17
Valuation at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 35.20 | 40.32 |
| Price-to-Sales Ratio (TTM) | 9.47 | 13.98 |
| Price-to-Book Ratio (MRQ) | 40.10 | 32.45 |
| Free Cash Flow Yield | 2.36% | 0.91% |
Profitability
Return on Equity (TTM)
Both Apple (AAPL) at 141.47% and Eli Lilly (LLY) at 107.46% turn shareholders’ equity into profit at rates above their industry benchmark ranges for ROE. That is a strong capital-efficiency signal, though leverage and the equity base still matter.
AAPL
Technology Hardware & Equipment industry group
141.47%
- AAPL
- 141.47%
- Max
- 44.16%
- Q3
- 19.25%
- Median
- 10.96%
- Q1
- 0.71%
- Min
- -25.92%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
107.46%
- LLY
- 107.46%
- Max
- 101.32%
- Q3
- 2.92%
- Median
- -31.26%
- Q1
- -62.68%
- Min
- -158.89%
Net Profit Margin (TTM)
Eli Lilly (LLY) at 34.99% keeps the most of each sales dollar — above its industry’s net margin range — and Apple (AAPL) at 27.15% also retains a top-quartile share.
AAPL
Technology Hardware & Equipment industry group
27.15%
- Max
- 30.43%
- AAPL
- 27.15%
- Q3
- 12.35%
- Median
- 4.45%
- Q1
- 0.00%
- Min
- -14.09%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
34.99%
- LLY
- 34.99%
- Max
- 12.76%
- Q3
- 4.00%
- Median
- 0.00%
- Q1
- -2.26%
- Min
- -11.53%
Operating Profit Margin (TTM)
Both Apple (AAPL) at 32.28% and Eli Lilly (LLY) at 49.39% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AAPL
Technology Hardware & Equipment industry group
32.28%
- Max
- 35.67%
- AAPL
- 32.28%
- Q3
- 15.55%
- Median
- 6.62%
- Q1
- 1.55%
- Min
- -18.45%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
49.39%
- Max
- 100.30%
- LLY
- 49.39%
- Q3
- 4.40%
- Median
- 0.00%
- Q1
- -131.52%
- Min
- -333.43%
Profitability at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| Return on Equity (TTM) | 141.47% | 107.46% |
| Return on Assets (TTM) | 26.23% | 20.74% |
| Net Profit Margin (TTM) | 27.15% | 34.99% |
| Operating Profit Margin (TTM) | 32.28% | 49.39% |
| Gross Profit Margin (TTM) | 47.86% | 82.83% |
Growth
Revenue Growth
Revenue Growth at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| 1-Year Revenue Growth | 6.43% | 44.70% |
| 3-Year Revenue CAGR | 1.81% | 31.69% |
EPS Growth
EPS Growth at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| 1-Year EPS Growth | 22.70% | 95.99% |
| 3-Year EPS CAGR | 6.88% | 51.71% |
Financial Strength
Current Ratio (MRQ)
Both Apple (AAPL) at 1.07 and Eli Lilly (LLY) at 1.50 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AAPL
Technology Hardware & Equipment industry group
1.07
- Max
- 5.80
- Q3
- 3.18
- Median
- 1.90
- Q1
- 1.28
- AAPL
- 1.07
- Min
- 0.40
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.50
- Max
- 24.81
- Q3
- 11.75
- Median
- 5.57
- Q1
- 2.69
- LLY
- 1.50
- Min
- 0.23
Debt-to-Equity Ratio (MRQ)
Apple (AAPL) at 0.80 carries an industry-typical debt-to-equity mix, while Eli Lilly (LLY) at 1.39 uses more debt funding than most peers.
AAPL
Technology Hardware & Equipment industry group
0.80
- Max
- 2.02
- Q3
- 0.88
- AAPL
- 0.80
- Median
- 0.31
- Q1
- 0.05
- Min
- 0.00
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.39
- Max
- 1.60
- LLY
- 1.39
- Q3
- 0.68
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| Current Ratio (MRQ) | 1.07 | 1.50 |
| Debt-to-Equity Ratio (MRQ) | 0.80 | 1.39 |
| Net Debt / EBITDA | 0.10 | 1.05 |
Dividends
Dividend Yield (TTM)
Apple (AAPL) at 0.37% pays an industry-typical yield; Eli Lilly (LLY) at 0.61% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.
AAPL
Technology Hardware & Equipment industry group
0.37%
- Max
- 1.30%
- Q3
- 0.54%
- AAPL
- 0.37%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.61%
- LLY
- 0.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Apple (AAPL) at 12.59% keeps its payout in the industry’s typical band, while Eli Lilly (LLY) at 22.13% pays out more than any of its peers — the most stretched cover in its group.
AAPL
Technology Hardware & Equipment industry group
12.59%
- Max
- 37.10%
- Q3
- 15.46%
- AAPL
- 12.59%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LLY
Pharmaceuticals, Biotechnology & Life Sciences industry group
22.13%
- LLY
- 22.13%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividends at a Glance
| Metric | AAPL | LLY |
|---|---|---|
| Dividend Yield (TTM) | 0.37% | 0.61% |
| Dividend Payout Ratio (TTM) | 12.59% | 22.13% |